Company / Free Cash Flow per Share
BioRestorative Therapies, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.58
FY2025
5-year range
-$4.70 / -$1.40
FY2021-FY2025
Trend
-12.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-4.70 in FY2021 to $-0.09 in FY2020.
Based on SEC 10-K filings.
-1.58 in FY2025.
Improved from $-1.79 to $-1.58 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 12.4% year-over-year.
- Peak free cash flow per share was recorded in FY2020.
- Lowest free cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.58 | -12.4% |
| FY2024 | -$1.40 | +21.9% |
| FY2023 | -$1.79 | -2.3% |
| FY2022 | -$1.76 | +62.6% |
| FY2021 | -$4.70 | -5157.6% |
| FY2020 | -$0.09 | +79.5% |
| FY2019 | -$0.44 | +30.9% |
| FY2018 | -$0.63 | +42.9% |
| FY2017 | -$1.10 | -3.6% |
| FY2016 | -$1.07 | +46.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026